World’s largest Parkinson’s study seeks 10,000 participants

News

Author: Simge Eva DoganPublished: 22 November 2018

Prep: Cook: Serves:

Predict-PD – a research project funded by Parkinson’s UK – is seeking volunteers to take part in what will be the world’s largest study on Parkinson’s.

The study – led by Queen Mary University of London, UK and University College London, UK – requires 10,000 volunteers aged 60 to 80 who have not been diagnosed with the condition.

Scientists will work with the participants using a variety of online assessments to develop a test that is able to diagnose Parkinson’s at an earlier rate than is currently possible.

Those taking part will be examined over a period of four years, completing tests on an annual basis until April 2021.

Dr Alastair Noyce, a neurologist who is leading the study along with Professor Anette Schrag at University College London, said: “We believe we can pick up people at least two years, if not five years, ahead of when they’d normally be diagnosed.”

To apply please visit the Predict-PD website.

To read more on this topic click here.

For more information on Parkinson’s diagnosis please visit the EPDA website.

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

Last Month

Next Month

Go Back

Share this story

Comments

Special reports

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Latest findings from 100 for Parkinson’s study released

Parkinson’s drugs may lead to compulsive behaviours such as gambling

The study tested 411 people over a three year period

6 world-class wildlife shots by a photographer with Parkinson’s

Wildlife photographer with Parkinson’s shares his favourite shots

New wearable medical device for Parkinson’s disease to launch this year

The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

Could a prostate drug lower the risk of Parkinson’s disease?

Researchers in the US, Denmark and China have found that a type of medication used to treat enlarged prostate, known as alpha-blockers, is associated with a lower risk of Parkinson’s disease. As part of the study, the research team analysed patient data from 150,000 men using medications like the alpha-blocker terazosin – which has previously been shown to slow Parkinson’s disease progression in animals – and compared their findings to data from 150,000 men using the alpha-blocker tamsulosin. They found that men taking terazosin were 12 to 37% less likely to develop Parkinson’s disease. Jacob Simmering, corresponding author of the study, said: “Despite the relative differences in population and health care system structure, we found a similar protective effect in both [the US and Denmark]. “If these results are confirmed through further investigation, especially a randomised clinical trial, terazosin may provide neuroprotection and potentially prevent – and not just manage…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

World’s largest Parkinson’s study seeks 10,000 participants

News

Author: Simge Eva DoganPublished: 22 November 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Special reports

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Special reports

Parkinson’s drugs may lead to compulsive behaviours such as gambling

Perspectives

6 world-class wildlife shots by a photographer with Parkinson’s

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

{title}

Subscribe

World’s largest Parkinson’s study seeks 10,000 participants

News

Author: Simge Eva DoganPublished: 22 November 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Special reports

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Special reports

Parkinson’s drugs may lead to compulsive behaviours such as gambling

Perspectives

6 world-class wildlife shots by a photographer with Parkinson’s

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

{title}

Subscribe

Sign in